Loading chat...

US SB5459

Bill

Status

Introduced

12/9/2024

Primary Sponsor

Marsha Blackburn

Click for details

Origin

Senate

118th Congress

AI Summary

Legislative Description

A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.

Last Action

Read twice and referred to the Committee on Finance.

12/9/2024

Committee Referrals

Finance12/9/2024

Full Bill Text

No bill text available